Does TADALAFIL Cause Off label use? 1,034 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,034 reports of Off label use have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 3.4% of all adverse event reports for TADALAFIL.
1,034
Reports of Off label use with TADALAFIL
3.4%
of all TADALAFIL reports
81
Deaths
294
Hospitalizations
How Dangerous Is Off label use From TADALAFIL?
Of the 1,034 reports, 81 (7.8%) resulted in death, 294 (28.4%) required hospitalization, and 46 (4.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 1,034 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TADALAFIL Alternatives Have Lower Off label use Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR